Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Feb;39(2):109-16.
doi: 10.1007/s40264-015-0378-5.

Appropriate Polypharmacy and Medicine Safety: When Many is not Too Many

Affiliations
Review

Appropriate Polypharmacy and Medicine Safety: When Many is not Too Many

Cathal A Cadogan et al. Drug Saf. 2016 Feb.

Abstract

The use of multiple medicines (polypharmacy) is increasingly common in middle-aged and older populations. Ensuring the correct balance between the prescribing of 'many' drugs and 'too many' drugs is a significant challenge. Clinicians are tasked with ensuring that patients receive the most appropriate combinations of medications based on the best available evidence, and that medication use is optimised according to patients' clinical needs (appropriate polypharmacy). Historically, polypharmacy has been viewed negatively because of the associated medication safety risks, such as drug interactions and adverse drug events. More recently, polypharmacy has been identified as a risk factor for under-prescribing, such that patients do not receive necessary medications and this can also pose risks to patients' safety and well-being. The negative connotations that have long been associated with the term polypharmacy could potentially be acting as a driving factor for under-prescribing, whereby clinicians are reluctant to prescribe necessary medicines for patients who are already receiving 'many' medicines. It is now recognised that the prescribing of 'many' medicines can be entirely appropriate in patients with several chronic conditions and that the risks of adverse drug events that have been associated with polypharmacy may be greatly reduced when patients' clinical context is taken into consideration. In this article, we outline the current perspectives on polypharmacy and make the case for adopting the term 'appropriate polypharmacy' in differentiating between the prescribing of 'many' drugs and 'too many' drugs. We also outline the inherent challenges in doing so and provide recommendations for future clinical practice and research.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Plot of cut-off indicator vs sensitivity and specificity (adapted from Belfrage et al. [27])
Fig. 2
Fig. 2
Structured approach for evaluating and managing older adults with multimorbidity (adapted from the American Geriatrics Society [34])

References

    1. Sumukadas D, McMurdo ME, Mangoni AA, Guthrie B. Temporal trends in anticholinergic medication prescription in older people: repeated crosssectional analysis of population prescribing data. Age Ageing. 2014;43(4):515–521. doi: 10.1093/ageing/aft199. - DOI - PubMed
    1. Hovstadius B, Hovstadius K, Astrand B, Petersson G. Increasing polypharmacy: an individual-based study of the Swedish population 2005–2008. BMC Clin Pharmacol. 2010;10:16. doi: 10.1186/1472-6904-10-16. - DOI - PMC - PubMed
    1. Franchi C, Tettamanti M, Pasina L, Djignefa CD, Fortino I, Bortolotti A, et al. Changes in drug prescribing to Italian community-dwelling elderly people: The EPIFARM-Elderly Project 2000–2010. Eur J Clin Pharmacol. 2014;70(4):437–443. doi: 10.1007/s00228-013-1621-6. - DOI - PubMed
    1. Hughes C, Cooper JA, Ryan C. Going beyond the numbers: a call to redefine polypharmacy. Br J Clin Pharmacol. 2014;77(6):915–916. doi: 10.1111/bcp.12284. - DOI - PMC - PubMed
    1. Guthrie B, Makubate B, Hernandez-Santiago V, Dreischulte T. The rising tide of polypharmacy and drug–drug interactions: population database analysis 1995–2010. BMC Med. 2015;13:74. doi: 10.1186/s12916-015-0322-7. - DOI - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources